ANIP 55.00 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 10:09 AM

ANIP 55.00 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high of 55.35 Closing the day 09:44 at 55.00 +1.05 +1.95% With a day low of 54.01 and a total volume of 45,608.

ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/

ANIP ANI Pharmaceuticals Inc Recent Headline News

Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 23 mins ago
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 55.62 (+1.67), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24), PBYI: 219.00 (+2.78)

Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 305.86 (+0.43), ANIP: 55.62 (+1.67), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24)

Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 55.62 (+1.67), ICPT: 159.01 (-3.57), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24)

Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 55.62 (+1.67)

ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 55.62 (+1.67), SCMP: 11.60 (+0.30)

Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 55.62 (+1.67)

Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 305.86 (+0.43), ANIP: 55.62 (+1.67), CLDX: 17.27 (+3.11), AMAG: 34.86 (+0.86)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.59 (+0.13), ANIP: 55.62 (+1.67), ACGL: 56.87 (-0.43), ACCO: 8.96 (-0.03), FLWS: 8.98 (-0.01)

ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 55.62 (+1.67)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.53 (-0.45), HBNK: 20.10 (+0.32), ASMI: 41.46 (+0.20), RRGB: 68.08 (-0.43), SAPE: 24.69 (+0.01), PLUG: 3.78 (+0.06), ANIP: 55.62 (+1.67), ODP: 6.57 (-0.22), MTEX: 21.41 (+1.10), JAXB: 11.75 (-0.15), ALQA: 5.07 (+0.02), YRCW: 23.96 (+0.23)

Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST

FRM: 6.14 (+0.06), NEO: 4.66 (-0.02), AU: 9.33 (-0.23), FNHC: 24.82 (+0.09), AMS: 2.53 (-0.19), NYMX: 0.58 (+0.03), AMDA: 1.39 (+0.17), CVD: 100.36 (+0.06), GBIM: 6.50 (+0.20), RCAP: 12.00 (-0.09), KBIO: 2.02 (-0.08), COOL: 0.85 (-0.05), SAPE: 24.69 (+0.01), XTLB: 2.58 (+0.13), GERN: 2.93 (+0.17), ANIP: 55.62 (+1.67), BBLU: 1.26 (-0.04), NXTD: 2.29 (-0.02), AP: 18.80 (-0.08), ALQA: 5.07 (+0.02)

ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST

ANIP: 55.62 (+1.67)

ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 55.62 (+1.67)

ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST

ANIP: 55.62 (+1.67)

ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014.
ANIP: 55.62 (+1.67)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST

ACW: 4.74 (-0.07), SYY: 38.78 (+0.20), L: 42.52 (-0.26), EEP: 37.56 (+0.22), SNH: 22.24 (+0.06), INN: 11.52 (-0.02), ITG: 19.70 (+0.19), NSP: 33.00 (+0.02), S: 5.03 (-0.02), ALE: 49.93 (+0.10), GVA: 36.44 (+0.17), MCY: 53.95 (-0.10), ARNA: 4.58 (+0.05), CHD: 73.44 (-0.09), ARE: 82.62 (+0.30), USAK: 18.44 (-0.01), BWP: 16.83 (-0.12), KRG: 26.17 (-0.03), CYOU: 23.50 (-0.37), MNKD: 6.08 (-0.08), HNT: 50.55 (+0.75), AMH: 17.24 (-0.03), ARCB: 42.78 (+0.17), ANIP: 55.62 (+1.67), AMG: 195.42 (-1.52), HAE: 37.12 (-0.01), SOHU: 50.14 (-0.82), CNA: 38.99 (-0.13)

ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 107.70 (+0.80), MACK: 8.63 (+0.15), ANIP: 55.62 (+1.67), ILMN: 180.99 (+0.49)

ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT

ANIP: 55.62 (+1.67)

5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 55.62 (+1.67), KTOS: 5.38 (-0.02), BLOX: 17.06 (+0.20), CSLT: 11.42 (-0.44), FPRX: 15.28 (+0.09)

ANI Pharmaceuticals Inc. (ANIP) Stock Research Links

ANIP Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...